Ondasetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial
Open Access
- 1 October 1994
- Vol. 74 (7) , 1945-1952
- https://doi.org/10.1002/1097-0142(19941001)74:7<1945::aid-cncr2820740720>3.0.co;2-c
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Effectiveness of a Single Intravenous Dose of OndansetronOncology, 1992
- Comparison of ondansetron with dexamethasone and domperidone in the prophylaxis of non-cisplatin chemotherapy induced emesis refractory to dexamethasoneEuropean Journal of Cancer and Clinical Oncology, 1991
- Randomized, double-blind cross-over study of acute cisplatin-induced nausea and vomiting, comparing a new schedule of the combination of metoclopramide and methylprednisolone versus metoclopramide aloneAnnals of Oncology, 1990
- Correlation of anti-emetic efficacy and plasma levels of ondansetronEuropean Journal of Cancer and Clinical Oncology, 1990
- Phase II Trials of the Serotonin Antagonist GR38032F for the Control of Vomiting Caused by CisplatinJNCI Journal of the National Cancer Institute, 1989
- Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonistBritish Journal of Cancer, 1988
- Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptorsBritish Journal of Pharmacology, 1988
- Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonismBritish Journal of Pharmacology, 1986
- Emesis as a Critical Problem in ChemotherapyNew England Journal of Medicine, 1981
- Superiority of Nabilone over Prochlorperazine as an Antiemetic in Patients Receiving Cancer ChemotherapyNew England Journal of Medicine, 1979